Innovation Pharmaceuticals Inc (IPIX)

[PJ007]

Read this carefully as there is a subliminal message in it!!!!!!!!!!

Brilacidin Human Coronavirus (H-CoV) Research: Scientists conducting laboratory testing of Brilacidin in endemic H-CoV strains (OC43, 229E, NL63) have informed the Company that they are reviewing potential venues to disseminate their findings, including conferences, via publication or through public release by the Company. These data show Brilacidin inhibits different H-CoV strains, supporting Brilacidin as a pan-coronavirus agent.